Exhibit 10.1
PERFORMANCE RESTRICTED STOCK EQUIVALENT AWARD AGREEMENT

In consideration of the mutual covenants contained herein, Energizer Holdings,
Inc. (“Company”), and __________________ (“Recipient”) hereby agree as follows:

ARTICLE I
COMPANY COVENANTS

Company hereby covenants:

1.    Award.
The Company, pursuant to its Amended and Restated 2009 Incentive Stock Plan (the
“Plan”), grants to Recipient a Restricted Stock Equivalent Award (“Performance
Equivalents”) of ______ restricted common stock equivalents (“Total Performance
Equivalents”). This Award Agreement is subject to the provisions of the Plan and
to the following terms and conditions.

2.    Vesting; Payment.
Vesting of the Performance Equivalents is contingent upon achievement of
performance targets for the period from October 1, 2012 through September 30,
2015 (the “Performance Period”). Provided that such Performance Equivalents have
not been forfeited pursuant to Section 5 below, a number of Performance
Equivalents will vest on the date that the Company publicly releases earnings
results for the third fiscal year of the Performance Period (the
“Vesting/Payment Date”) equal to the following formula:
Base Metric Equivalents x Relative TSR Modifier
where Base Metric Equivalents is defined as:
(Total Performance Equivalents x ROIC Factor x 50%) + (Total Performance
Equivalents x Cumulative EBITDA Factor x 50%)
provided that no award will be greater than the Total Performance Equivalents,
or less than zero.
Relative TSR Modifier
The Relative TSR Modifier is calculated as follows. The Relative TSR shall
modify the number of awards granted as shown in the table below, with pro rata
increases, at 1/10th of 1% increments, between each listed percentage.
***Table***

Relative TSR is defined as the TSR of the Company as compared to the TSR of the
TSR Comparator Group companies.
TSR will be calculated based on the following formula:
(((Ending share price + total dividends) / beginning share price)^(1/# of
years))-1
The result will be expressed as a percentage. For this purpose, the beginning
stock price will be the volume-weighted average closing stock price (VWAP) for
the 20 trading days immediately preceding the performance period and the ending
stock price will be the VWAP in the last 20 trading days of the performance

--------------------------------------------------------------------------------

period. Total dividends will be the aggregate amount of dividends per share of
common stock, the record date of which occurred during the performance period.
The TSR Comparator Group for the Performance Period is Avon Products, Beiersdorf
AG, Church & Dwight Inc., The Clorox Company, Colgate-Palmolive Co., Elizabeth
Arden Inc., Hasbro Inc., Henkel AG & CO, Herbalife Ltd., Jarden Corp.,
Kimberly-Clark Corporation, Lauder (Estee) Companies, Inc., Loreal Co., Mattel
Inc., Mead Johnson Nutrition Co., Newell Rubbermaid, Inc., Nu Skin Enterprises,
Procter & Gamble Co., Reckitt Benckiser Group PLC, Spectrum Brands Holdings Inc.
If a member is added or deleted from the TSR Comparator Group during the
three-year performance period by the Committee due to a merger, liquidation or
other corporate event, such change will be made retroactively to the beginning
of such performance period.
ROIC Factor
The ROIC Factor is calculated as follows. Adjusted Return on Invested Capital is
calculated by dividing Operating Profit After Taxes by the Company's Invested
Capital Base.
Operating Profit After Taxes means the average over the performance period of
annual earnings before income taxes plus interest expense and other financing
items, net of tax at effective rate of 31%, adjusted to exclude:
•
unusual or non-recurring accounting impacts or changes in accounting standards
or treatment;

•
non-cash costs associated with events such as plant closings, sales of
facilities or operations, and business restructurings; or

•
unusual or extraordinary non-cash items.

Invested Capital Base means the average of an amount equal to total
shareholders' equity plus current maturities of long-term debt, notes payable
and long-term debt, as of the end of the quarterly period immediately prior to
the performance period and each quarterly period end during the performance
period, adjusted to add back:
•
unusual or non-recurring accounting impacts or changes in accounting standards
or treatment;

•
non-cash costs associated with events such as plant closings, sales of
facilities or operations, and business restructurings; or

•
unusual or extraordinary non-cash items.

Upon an acquisition, divestiture, restructuring or other corporate transaction,
the Committee shall have the authority to adjust the ROIC performance targets
based on the projected impact of the acquisition, divestiture, restructuring or
other corporate transaction on Operating Profit After Taxes and Invested Capital
Base during the performance period.
The ROIC Factor will be a percentage based on Adjusted Return on Invested
Capital at the end of the Performance Period equal to 10% at Threshold, 50% at
Target and 100% at Stretch, as shown in the table below, with pro rata
increases, at 1/10th of 1% increments, between each listed percentage.

***Table***

Cumulative EBITDA Factor
The Cumulative EBITDA Factor is calculated as follows. Adjusted Cumulative
EBITDA means the sum of earnings before income taxes plus interest and other
financing items, depreciation, amortization and miscellaneous expenses, for the
performance period, adjusted to exclude:
•
the effects of acquisitions; divestitures; or recapitalizations;  

--------------------------------------------------------------------------------

•
a corporate transaction, such as any merger of the Company with another
corporation; any consolidation of the Company and another corporation into
another corporation; any separation of the Company or its business units
(including a spin-off or other distribution of stock or property by the
Company);

•
any reorganization of the Company (whether or not such reorganization comes
within the definition of such term in Code Section 368); or any partial or
complete liquidation by the Company; or sale of all or substantially all of the
assets of the Company;

•
unusual or non-recurring accounting impacts or changes in accounting standards
or treatment;

•
non-cash costs associated with events such as plant closings, sales of
facilities or operations; and business restructurings; or

•
unusual or extraordinary non-cash items.

The Cumulative EBITDA Factor will be a percentage based on Adjusted Cumulative
EBITDA at the end of the Performance Period equal to 10% at Threshold, 50% at
Target and 100% at Stretch, as shown in the table below, with pro rata
increases, at 1/10th of 1% increments, between each listed percentage.

***Table***

Upon vesting, as described above, the Company shall transfer to the Recipient or
his or her beneficiary one share of the Company's $0.01 par value Common Stock
(“Common Stock”) for each Performance Equivalent that so vests. Such shares of
Common Stock shall be issued to the Recipient or his or her beneficiary on, or
as soon as practicable after, the Vesting/Payment Date, but in no event later
than the 15th day of the third month following the end of the calendar year in
which such Vesting/Payment Date occurs. Any Performance Equivalents that are
scheduled to vest on such Vesting/Payment Date that do not so vest because the
performance criteria related to such Performance Equivalents was not achieved
shall be forfeited and the Recipient and his or her beneficiaries will have no
further rights with respect thereto.
3.    Additional Cash Payment.
On the Vesting/Payment Date on which Performance Equivalents vest, the Company
shall pay the Recipient or his or her beneficiary an amount equal to the amount
of cash dividends, if any, that would have been paid to the Recipient between
the date hereof and such Vesting/Payment Date had vested shares of Common Stock
been issued to the recipient in lieu of the Performance Equivalents that so
vested. Such amounts shall be paid in a single lump-sum as soon as practicable
following such Vesting/Payment Date, but in no event later than the 15th day of
the third month following the end of the calendar year in which such
Vesting/Payment Date occurs. No interest shall be included in the calculation of
such additional cash payment.
4.    Acceleration.
Notwithstanding the provisions of paragraph 2 above, all Performance Equivalents
then outstanding will immediately vest, in the event of the Recipient's death.
Upon a Change of Control, the Performance Equivalents that will immediately
vest upon such Change of Control will be the greater of:
 (a)        50% of the total Performance Equivalents granted, or
(b)        the amount of such Performance Equivalents which would have vested
had the Measurement Period ended on the date the Change of Control occurs based
on the Committee's determination of the extent to which performance goals with
respect to that Measurement Period have been met based on such audited or
unaudited financial information or other information then available that the
Committee deems relevant.

--------------------------------------------------------------------------------

Upon vesting, as described in this Section 4, the Company shall transfer to the
Recipient or his or her beneficiary one share of the Company's Common Stock for
each Performance Equivalent that so vests. Such shares of Common Stock shall be
issued to the Recipient or his or her beneficiary on, or as soon as practicable
after, the date of the Recipient's death or the date of the Change of Control,
but in no event later than the 15th day of the third calendar month following
the end of the calendar year in which the Recipient's death or the Change of
Control occurs.
5.    Forfeiture.
All rights in and to any and all Performance Equivalents granted pursuant to
this Award Agreement, and to any shares of Common Stock that would be issued to
the Recipient in connection with the vesting of such Performance Equivalent,
which have not vested by the Vesting/Payment Date, as described in paragraph 2
above, or as described in paragraph 4 above, shall be forfeited. In addition,
all rights in and to any and all Performance Equivalents granted pursuant to
this Award Agreement which have not vested in accordance with the terms hereof,
and to any shares of Common Stock that would be issued to the Recipient in
connection with the vesting of such Performance Equivalent, shall be forfeited
upon:
(a)
the Recipient's voluntary or involuntary Termination of Employment; or

(b)
a determination by the Committee that the Recipient engaged in competition with
the Company or other conduct contrary to the best interests of the Company in
violation of Article II of this Agreement.

6.    Shareholder Rights; Adjustment of Equivalents.
Recipient shall not be entitled, prior the issuance of shares of Common Stock in
connection with the vesting of a Performance Equivalent, to any rights as a
shareholder with respect to such shares of Common Stock, including the right to
vote, sell, pledge, transfer or otherwise dispose of the shares. Recipient
shall, however, have the right to designate a beneficiary to receive such shares
of Common Stock under this Award Agreement, subject to the provisions of Section
V of the Plan. The number of Performance Equivalents credited to Recipient shall
be adjusted in accordance with the provisions of Section VI(F) of the Plan.
7.    Other.
The Company reserves the right, as determined by the Nominating and Executive
Compensation Committee of the Board of Directors of the Company (the
“Committee”), to convert the Performance Equivalents granted pursuant to this
Award Agreement to a substantially equivalent award and to make any other
modification it may consider necessary or advisable to comply with any
applicable law or governmental regulation, or to preserve the tax deductibility
of any payments hereunder. Notwithstanding the foregoing, the Company shall not
so convert such Performance Equivalents to the extent such conversion could
result in the imposition of negative tax consequences for the Recipient under
Code Section 409A. Shares of Common Stock shall be withheld in satisfaction of
federal, state, and local or other international withholding tax obligations
arising upon the vesting of Equivalents. Shares of Common Stock tendered as
payment of required withholding shall be valued at the Fair Market Value of the
Company's Common Stock on the date such withholding obligation arises.

8.    Code Section 409A.

It is intended that this Award Agreement either be exempt from or comply with
the requirements of Code Section 409A. The Plan will be administered and
interpreted in a manner consistent with this intent, and any provision that
would cause the Agreement to fail to satisfy Code Section 409A will have no
force and effect until amended to comply therewith (which amendment may be
retroactive to the extent permitted

--------------------------------------------------------------------------------

by Code Section 409A). Notwithstanding any other provision of this Award
Agreement or the Plan to the contrary, if a Recipient is considered a “specified
employee” for purposes of Code Section 409A, any payment that constitutes
“deferred compensation” within the meaning of Code Section 409A that is
otherwise due to the Recipient as a result of such Recipient's “separation from
service” under this Award Agreement or the Plan during the six-month period
immediately following Recipient's “separation from service” shall be accumulated
and paid to the Recipient on the first day of the seventh month following such
“separation from service”.
9.    Definitions.
Affiliates shall mean all entities within the controlled group that includes the
Company, as defined in Code Sections 414(b) and 414(c) and the regulations
thereunder, provided that the language “at least 50 percent” shall be used
instead of “at least 80 percent” each place it appears in such definition.

Change of Control shall mean the either of the following, provided that the
following constitutes a “change in the ownership” of the Company or “change in
the ownership of a substantial portion of the Company's assets” within the
meaning of Code Section 409A:

(i)
The acquisition by one person, or more than one person acting as a group, of
ownership of stock (including Common Stock) of the Company that, together with
stock held by such person or group, constitutes more than 50% of the total fair
market value or total voting power of the stock of the Company. Notwithstanding
the above, if any person or more than one person acting as a group, is
considered to own more than 50% of the total fair market value or total voting
power of the stock of the Company, the acquisition of additional stock by the
same person or persons will not constitute a Change of Control; or

(ii)
A majority of the members of the Company's Board of Directors is replaced during
any twelve-month period by directors whose appointment or election is not
endorsed by a majority of the members of the Company's Board of Directors before
the date of the appointment or election.

Persons will not be considered to be acting as a group solely because they
purchase or own stock of the same corporation at the same time, or as a result
of the same public offering. However, persons will be considered to be acting as
a group if they are owners of a corporation that enters into a merger,
consolidation, purchase or acquisition of stock, or similar business transaction
with the Company.

Termination of Employment shall mean a “separation from service” with the
Company and its Affiliates, within the meaning of Code Section 409A.

ARTICLE II    
RECIPIENT COVENANTS
Recipient hereby covenants:

1.    Confidential Information.
By executing this Award Agreement, I agree that I shall not, directly or
indirectly, use, make available, sell, disclose or otherwise communicate to any
person, other than in the course of my assigned duties and for the benefit of
the Company, either during the period of my employment or at any time
thereafter, any nonpublic, proprietary or confidential information, knowledge or
data relating to the Company, any of its affiliates, or their businesses, which
I shall have obtained during my employment by the Company or an affiliate. The
foregoing shall not apply to information that (a) was known to the public prior
to its disclosure to me; (b) becomes known to the public subsequent to
disclosure to me through no wrongful act or mine or

--------------------------------------------------------------------------------

any of my representatives; or (c) I am required to disclose by applicable law,
regulation or legal process (provided that I provide the Company with prior
notice of the contemplated disclosure and reasonably cooperate with the Company
at its expense in seeking a protective order or other appropriate protection of
such information). Notwithstanding clauses (a) or (b) of the preceding sentence,
my obligation to maintain such disclosed information in confidence shall not
terminate if only portions of the information are in the public domain.
2.    Non-Competition.
By executing this Award Agreement, I acknowledge that my services are of a
unique nature for the Company that are irreplaceable, and that my performance of
such services for a competing business will result in irreparable harm to the
Company and its affiliates. Accordingly, during my employment with the Company
or any affiliate and for the ___ year period thereafter, I agree that I will
not, directly or indirectly, own, manage, operate, control, be employed by
(whether as an employee, consultant, independent contractor or otherwise, and
whether or not for compensation) or render services to any person, firm,
corporation or other entity, in whatever form, engaged in any business of the
same type as any business in which the Company or any of its affiliates is
engaged on the date of termination or in which they have proposed, on or prior
to such date, to be engaged in on or after such date and in which I have been
involved to any extent (on other than a de minimus basis) at any time during the
___ year period ending with my date of termination, in any locale of any country
in which the Company or any of its affiliates conducts business. This subsection
shall not prevent me from owning not more than one percent of the total shares
of all classes of stock outstanding of any publicly held entity engaged in such
business. I agree that the foregoing restrictions are reasonable, necessary, and
enforceable for the protection of the goodwill and business of the Company.

3.    Non-Solicitation.
During my employment with the Company or an affiliate and for the two (2) year
period thereafter, I agree that I will not, directly or indirectly, individually
or on behalf of any other person, firm, corporation or other entity, knowingly
solicit, aid or induce (a) any employee of the Company or any affiliate to leave
such employment in order to accept employment with or render services to or with
any other person, firm, corporation or other entity unaffiliated with the
Company or knowingly take any action to hire or to materially assist or aid any
other person, firm, corporation or other entity in identifying or hiring any
such employee, or (b) any customer of the Company or any affiliate to purchase
goods or services then sold by the Company or any affiliate from another person,
firm, corporation or other entity or assist or aid any other persons or entity
in identifying or soliciting any such customer. I agree that the foregoing
restrictions are reasonable, necessary, and enforceable in order to protect the
Company's trade secrets, confidential and proprietary information, goodwill, and
loyalty.
4.    Non-Disparagement.
I agree not to make any statements that disparage the Company or its affiliates
or their respective employees, officers, directors, products or services, and
the Company, by its execution of this Award Agreement agrees that it and its
affiliates and their respective executive officers and directors shall not make
any such statements regarding me. Notwithstanding the foregoing, statements made
in the course of sworn testimony in administrative, judicial or arbitral
proceedings (including, without limitation, depositions in connection with such
proceedings) shall not be subject to this subsection.
5.    Reasonableness.
In the event any of the provisions of this Article II shall ever be deemed to
exceed the time, scope or geographic limitations permitted by applicable laws,
then such provisions shall be reformed to the maximum time, scope or geographic
limitations, as the case may be, permitted by applicable laws.

--------------------------------------------------------------------------------

6.    Equitable Relief.
(a)
I acknowledge that the restrictions contained in this Article II are reasonable
and necessary to protect the legitimate interests of the Company and its
affiliates, that the Company would not have granted me this Award Agreement in
the absence of such restrictions, and that any violation of any provisions of
this Article II will result in irreparable injury to the Company and its
affiliates. By agreeing to accept this Award Agreement, I represent that my
experience and capabilities are such that the restrictions contained herein will
not prevent me from obtaining employment or otherwise earning a living at the
same general level of economic benefit as is currently the case. I further
represent and acknowledge that I have been advised by the Company to consult my
own legal counsel in respect of this Award Agreement, and I have had full
opportunity, prior to agreeing to accept this Award Agreement, to review
thoroughly its terms and provisions with my counsel.

(b)
I agree that the Company shall be entitled to preliminary and permanent
injunctive relief, without the necessity of proving actual damages, as well as
an equitable accounting of all earnings, profits and other benefits arising from
any violation of this Article II, which rights shall be cumulative and in
addition to any other rights or remedies to which the Company may be entitled.

(c)
I irrevocably and unconditionally consent to the service of any process,
pleadings notices or other papers in a manner permitted by law.

7.    Waiver; Survival of Provisions.
The failure by the Company to enforce at any time any of the provisions of this
Article II or to require at any time performance by me of any provisions hereof,
shall in no way be construed to be a release of me or waiver of such provisions
or to affect the validity of this Award Agreement or any part hereof, or the
right of the Company thereafter to enforce every such provision in accordance
with the terms of this Award Agreement. The obligations contained in this
Article II shall survive the termination of my employment with the Company or
any affiliate and shall be fully enforceable thereafter.

ARTICLE III
OTHER AGREEMENTS
1.    Governing Law.

All questions pertaining to the validity, construction, execution, and
performance of this Award Agreement shall be construed in accordance with, and
be governed by, the laws of the State of Missouri, without giving effect to the
choice of law principles thereof.

2.    Notices.
Any notices necessary or required to be given under this Award Agreement shall
be sufficiently given if in writing, and personally delivered or mailed by
registered or certified mail, return receipt requested, postage prepaid, to the
last known addresses of the parties hereto, or to such other address or
addresses as any of the parties shall have specified in writing to the other
party hereto.

3.    Entire Agreement.

--------------------------------------------------------------------------------

This Award Agreement constitutes the entire agreement of the parties hereto with
respect to the matters contained herein, and no modification, amendment, or
waiver of any of the provision of this Award Agreement shall be effective unless
in writing and signed by all parties hereto. This Award Agreement constitutes
the only agreement between the parties hereto with respect to the matters herein
contained.

4.    Waiver.
No change or modification of this Award Agreement shall be valid unless the same
is in writing and signed by all the parties hereto. No waiver of any provision
of this Award Agreement shall be valid unless in writing and signed by the party
against whom it is sought to be enforced.

5.    Counterparts; Effect of Recipient's Signature.
This Award Agreement may be executed in one or more counterparts, each of which
shall be deemed an original, and all of which shall constitute one and the same
agreement and shall become effective when one or more counterparts have been
signed by each of the parties and delivered to the other party, it being
understood that both parties need not sign the same counterpart. The provisions
of this Award Agreement shall not be valid and in effect until such execution by
both parties. By the execution of this Award Agreement, Recipient signifies that
Recipient has fully read, completely understands, and voluntarily agrees with
this Award Agreement consisting of nine (9) pages and knowingly and voluntarily
accepts all of its terms and conditions.

6.    Effective Date.
This Award Agreement shall be deemed to be effective as of the date executed.
[the remainder of this page is left intentionally blank; signature page follows]

IN WITNESS WHEREOF, the Company duly executed this Award Agreement as of (Date)
and Recipient duly executed it as of ________________________, 2012.

ACKNOWLEDGED AND ACCEPTED:        ENERGIZER HOLDINGS, INC.

__________________________________        By: _______________________________
Recipient                         Ward M. Klein
Chief Executive Officer